NYSE:PFE

Pfizer Inc (PFE)

25.01
+0.10 (0.40%)
as of Jul 31, 2026, 8:00:00 pm Market Open.
581 watching
0
Investor Insights
star iconAug 2, 2026, 12:00 am

This summary was created by AI, based on 23 opinions in the last 12 months.

Pfizer Inc. (PFE) is currently facing challenges following its pandemic-driven peak during which it surged due to COVID-19 vaccine sales. Experts have pointed out a lack of earnings momentum and concerns over a patent cliff, as key drugs have come off patent and the company needs to innovate to develop new blockbuster drugs. Despite these challenges, many analysts emphasize the attractive dividend yield, which remains around 6-8%. The company is pivoting towards growth areas such as obesity and oncology, and while there's a general belief that PFE is under pressure, patience from investors could yield positive results. Several insights indicate that while it may not attract immediate growth, the company’s efforts in acquisitions and drug development could eventually pay off, given time.

consensus icon
Consensus
Hold
valuation icon
Valuation
Undervalued
review icon
Similar
MRK
PAST TOP PICK
(Was a top pick on Apr 16/03. Not much change.) Still likes. Continuing to buy at this price.
PAST TOP PICK
(Was a top pick on Mar 31/03. Up 6.8%) Still likes. Merger with Pharmacia gives them a very powerful potent drug patent.
HOLD
Questioner: "Why is it stuck in a $30/31 range?" Response: "Likes at this price. Their drugs and pipeline are good. Has a lot of cash."
BUY
A favourite drug stock in their funds. Earnings growth should be 15% over the next several years. Dividend yield is decent. Has a very good pipeline of drugs.
TOP PICK
Just completed a good merger with Pharmacia. Good pipeline.
TOP PICK
Just got approval on new products and should move up.
DON'T BUY
More expensive in the drug sector. Merk is a better buy.
BUY
Pretty good value. The merger will allow some cost cutting. A good price.
BUY
HOLD
Well run and strong management. Has grown so big that future growth is difficult.
BUY
Not doing much, but a good stock to own.
BUY
Likes the pharmaceutical group. Acquisition of Pharmacia is positive.
BUY
Likes. Great value.
HOLD
Good merger made. Good company.
BUY
Positive on the drug industry.
Showing 781 to 795 of 885 entries